Home > Healthcare > Medical Devices > Diagnostic Devices > Cancer Diagnostics Market

Cancer Diagnostics Market Share

  • Report ID: GMI2406
  • Published Date: Jan 2023
  • Report Format: PDF

Cancer Diagnostics Market Share

Some of the leading companies in the global cancer diagnostics market include

  • Agilent Technologies Inc
  • Abbott Laboratories
  • Becton
  • Dickinson and Company
  • AB Sciex Pte. Ltd
  • Biocare Medical LLC
  • BioMerieux SA
  • Biocartis
  • Bio-Rad Laboratories
  • GE Healthcare
  • Janssen Diagnostics LLC (Johnson & Johnson)
  • Cancer Genetics Inc
  • Hologic Inc
  • Leica Biosystem Nussloch GmbH (Danaher Corporation)
  • Qiagen N.V
  • F-Hoffmann-La Roche Ltd
  • Myriad Genetics, Inc
  • Siemens Healthineers
  • Thermo Fischer Scientific
  • Sysmex Corporation

These firms are developing advanced products with superior performance capabilities for better consumer traction.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for cancer diagnostics was worth more than USD 136 billion in 2022 and is projected to exhibit over 9% CAGR from 2023-2032.

Non-Hodgkin lymphoma (NHL) is estimated to reach over USD 18.5 billion by 2032 due to increasing prevalence in the aging population.

Europe cancer diagnostics market size is slated to surpass USD 93.5 billion by 2032 owing to the presence of growing healthcare expenditure and supportive initiatives.

Abbott Laboratories, BioMerieux SA, Biocartis, Hologic Inc, Qiagen N.V, Myriad Genetics, Inc, and Sysmex Corporation are some key participants in the market.

Cancer Diagnostics Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 19
  • Tables & Figures: 274
  • Countries covered: 18
  • Pages: 300
 Download Free Sample